Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT05168774Phase 1/2Completed
FRDA Investigator Initiated Study (IIS) With Elamipretide
Friedreich Ataxia
PrincipalinvestigatorStart date: 2022-03-03
NCT03418740Completed
Neurology Measures in FA Children
Friedreich Ataxia
PrincipalinvestigatorStart date: 2017-11-20
NCT01035671Phase 2Completed
Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
Friedreich's Ataxia
Principalinvestigator
NCT01965327Phase 2Completed
Interferon Gamma-1b in Friedreich Ataxia (FRDA)
Friedreich Ataxia
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Children's Hospital of Philadelphia

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ludger Schöls, MD

University of Tübingen, Dept. of Neurology with Hertie-Institute for Clinical Brain Research

Moderately Similar
1 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Richard Walsh, MD

Tallaght University Hospital, Department of Neurology

Moderately Similar
1 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Theresa A Zesiewicz, MD

University of South Florida

Moderately Similar
6 trials

Shared therapeutic areas:

Friedreich Ataxia

Worked with same sponsors:

Friedreich's Ataxia Research Alliance
Similarity Score30%

Massimo Pandolfo, M.D.

Hospital Erasme, Brussels, Belgium

Moderately Similar
2 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Martin Vyhnálek, MD

Motol University Hospital, Centre for Hereditary Ataxias

Moderately Similar
1 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Francisco J. Rodriguez de Rivera Garrido, MD

La Paz University Hospital, Dept. of Neurology

Moderately Similar
1 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Barbara Borroni, MD

Azienda Ospedaliera Spedali Civili, Brescia

Moderately Similar
7 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Alexandra Durr, MD

Hôpital Pitié Salpêtrière, ICM

Moderately Similar
1 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Caterina Mariotti, MD

Fondazione IRCCS Istituto Neurologico Carlo Besta

Moderately Similar
1 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Bart van de Warrenburg, MD

STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM

Moderately Similar
1 trials

Shared therapeutic areas:

Friedreich Ataxia
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT05168774Phase 1/2PrincipalInvestigator

FRDA Investigator Initiated Study (IIS) With Elamipretide

Friedreich Ataxia
Completed
NCT03418740PrincipalInvestigator

Neurology Measures in FA Children

Friedreich Ataxia
Completed
NCT01035671Phase 2PrincipalInvestigator

Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia

Friedreich's Ataxia
Completed
NCT01965327Phase 2PrincipalInvestigator

Interferon Gamma-1b in Friedreich Ataxia (FRDA)

Friedreich Ataxia
Completed

All 4 trials loaded